Israel: Market and regulatory data analysis of the cannabis sector

18th April 2024: Israel: The Medical Cannabis Unit has updated Procedure 110, which sets out guidelines for the process of approving medical cannabis export licence applications. To get a licence, exporters are now required to obtain an “export permit” from the Customs Administration as well as an “export licence of dangerous drugs” from the Import-Export Department at the Medical Cannabis Unit by email to import-export.yakar@moh.gov.il.
25th January 2024: Israel: The Medical Cannabis Unit has published a proposed amendment to the procedure for obtaining the Medical Cannabis Good Agricultural Practices (IMC-GAP) and Good Security Practices (IMC-GSP) certificates. The new proposal, which is part of the Ministry of Health’s new reform regarding medical cannabis, will ease the process of obtaining the authorisation and cut the time needed to resolve the application. The proposal will be available for public comments until 11th February.
8th January 2024: Israel: The Medical Cannabis Unit has published for public consultation a draft on the amendments to the procedure to obtain a medical cannabis licence as part of the Ministry of Health’s comprehensive reform. The main amendments concern procedure 106 – licences for medical cannabis use and procedure 107 – process to obtain a licence to produce cannabis for medical use, and focus on reducing fees and simplifying the process for obtaining licences for medical cannabis use and production. The consultation ends on 21st January 2024.
30th October 2023: Israel: The Medical Cannabis Unit published a warning against the use of cannabis after traumatic events. The warning emphasises that cannabis has not been proven effective for the acute phase following trauma and may even be harmful. It recommends that cannabis treatment is only deemed appropriate for chronic conditions, and only after talk therapies or research-based drug treatments.
19th October 2023: Israel: Today the Ministry of Health published for public consultation a proposal to defer the effective date of the amendment to the Dangerous Drugs Ordinance from 29th December 2023 to 29th March 2024. The Health Committee of the Knesset (parliament) and the health minister signed the amendments in June 2023, imposing new rules for licensing medical cannabis for patients, producers and growers; simplifying the licensing process; and reducing approval timelines. The public should submit comments before 2nd November 2023.
9th October 2023: Israel: The Ministry of Health has issued an order stating that patients and businesses with medical cannabis licences that have expired or will expire within the next month who can’t renew due to the current situation in the country will receive an automatic renewal for three months from the actual expiry date. A copy of the extension will be sent to the licensees by email.
3rd October 2023: Israel: The Medical Cannabis Unit invites the public to submit their comments to the committee reviewing phytocannabinoids. The committee will formulate decisions regarding the exclusion of products or parts of the cannabis plant that have an intoxicating psychoactive effect from the definition of “dangerous drug” in the Dangerous Drugs Ordinance. The committee will not discuss excluding THC from the definition of a dangerous drug. The public should send their comment by email before 29th October 2023.
15th September 2023: Israel: The Medical Cannabis Unit has published for public consultation a draft table on the categories of medical cannabis products it has approved. The table lists the products, their categories, and their THC, CBD and cannabinol (CBN) concentrations. The consultation ends on 24th September. Israel’s new reform on the use of medical cannabis laid down new rules, with products classified by categories, and published on the Medical Cannabis Unit website, to ensure precise concentration indications to combat high THC consumption and non-medical marketing in Israeli pharmacies.
16th August 2023: Israel: The Ministry of Health published the outline of its new reform on the use of medical cannabis last week. The new rules lift some of the regulatory restrictions on growers and producers of medical cannabis, ease the licensing process, and reduce the timeline for approval to 14 days. In addition, patients with specific conditions like cancer, Crohn’s disease, dementia, autism, multiple sclerosis and HIV can now get prescriptions from their doctors without obtaining a licence. The new regulation will come into effect in December 2023.
29th May 2023: Israel: The Ministry of Health has again issued a warning against the use of e-cigs containing synthetic cannabinoids (ADB-BUTINACA and MDMB-4en-Pinaca) known as “Nice Guy”. They are sold illegally under the brand names RM Premium, Snoop Dogg, Fume Orjoy, Premium Vape, and The Bulldog and cause severe mental and physical effects such as psychosis, anxiety and panic attacks, cerebral edema, kidney damage, heart damage and bleeding in the digestive system.
9th January 2023: Israel: The Ministry of Health has issued a warning against the use of e-cigs containing synthetic cannabinoids (ADB-BUTINACA and MDMB-4en-Pinaca) known as “Nice Guy”, which is sold illegally under the brand names Premium Vape, Snoop Dogg, and The Bulldog and causes severe mental and physical effects such as psychosis, hallucinations, anxiety, panic attacks, bleeding, cerebral oedema, kidney damage and damage to the heart, press reports.

LATEST ALERTS

Cannabis and cannabinoids in Israel

News analysis

IMC 2022 revenue up 60% as it leaves Canada, focuses on Israel and Germany

Cronos sees losses down, net revenue up due to higher sales in Canada and Israel

Is 2023 the year for the great leap forward on cannabis regulation?

UK scientist says medicinal cannabis research in the country lagging behind

Israeli cannabis firms expand into Europe, bringing Cookies to Vienna

Alerts

Market reports

Israel: medical cannabis snapshot

Regulatory reports

Israel: CBD and cannabis regulation, November 2023

Israel: medical cannabis snapshot

Israel: CBD and cannabis regulation, May 2022

Medical and recreational cannabis – a global overview

Regulation of CBD in edibles: an international overview

Market data

Medical cannabis retail price tracker

Regulatory databases

Regulatory tracker: current global regulation of CBD, February

Regulatory tracker: current global regulation of recreational cannabis

Regulatory tracker: current global regulation of medical cannabis

Medical cannabis comparative analysis database

Regulatory tracker: how 50 different countries regulate CBN and CBG

Sign up to our newsletter